Comparing Contrast-Enhanced Color Flow Imaging and Pathological Measures of Breast Lesion Vascularity

Ultrasound in Medicine and Biology

Volumn 34, Issue 9, 2008, Pages 1365-1372

  Forsberg, Flemming ^a   Kuruvilla, Babita ^a,b   Pascua, Mark B ^a   Chaudhari, Manisha H ^a,b   Merton, Daniel A ^a   Palazzo, Juan P ^a   Goldberg, Barry B ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DREXEL UNIVERSITY   (United States)

Author keywords

Breast cancer; Color flow imaging; Microvessel density; Tumor vascularity; Ultrasound contrast agent

Indexed keywords

BEFORE AND AFTER; BREAST CANCER; BREAST LESIONS; BREAST MASSES; COLOR FLOW IMAGING; COLOR PIXELS; CONTRAST-ENHANCED; FIRST ORDERS; IMAGE-PROCESSING SOFTWARE; MALIGNANT LESIONS; MICROVESSEL AREA; MICROVESSEL DENSITY; PHILIPS MEDICAL SYSTEMS; QUANTIFIABLE MEASURES; SOLID BREAST MASSES; STEPWISE MULTIPLE LINEAR REGRESSION; TUMOR VASCULARITY; ULTRASOUND CONTRAST AGENT; ULTRASOUND IMAGES;

ACOUSTIC WAVES; BLOOD VESSELS; COLOR; ENDOTHELIAL CELLS; FLOW VISUALIZATION; FLUID DYNAMICS; FLUID MECHANICS; FOOD PROCESSING; HEALTH; IMAGE ENHANCEMENT; IMAGE PROCESSING; IMAGING SYSTEMS; IMAGING TECHNIQUES; OPTICAL DATA PROCESSING; OPTICAL PROPERTIES; PAINTING; PATHOLOGY; REGRESSION ANALYSIS; SCANNING; ULTRASONICS;

ULTRASONIC IMAGING;

SHU 508;

ADULT; AGED; ARTICLE; BREAST CANCER; CLINICAL ARTICLE; COLOR ULTRASOUND FLOWMETRY; CONTRAST ENHANCEMENT; CONTROLLED STUDY; FEMALE; HUMAN; IMAGE ANALYSIS; MAMMOGRAPHY; PRIORITY JOURNAL; TUMOR VASCULARIZATION; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; BLOOD FLOW VELOCITY; BREAST DISEASES; BREAST NEOPLASMS; CONTRAST MEDIA; FEMALE; HUMANS; IMAGE ENHANCEMENT; LINEAR MODELS; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PILOT PROJECTS; POLYSACCHARIDES; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, DOPPLER, COLOR; ULTRASONOGRAPHY, MAMMARY; YOUNG ADULT;

EID: 49849086285     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2008.02.010     Document Type: Article

References (41)

1. Adler D.D., Carson P.L., Rubin J.M., and Quinn-Reid D. Doppler ultrasound color flow imaging in the study of breast cancer: Preliminary findings. Ultrasound Med Biol 16 (1990) 553-559
2. Barbareschi M., Weidner N., Gasparini G., Morelli L., Forti S., Eccher C., Fina P., Caffo O., Leonardi E., Mauri F., Bevilacqua P., and Palma P.D. Microvessel density quantification in breast carcinomas: Assessment by manual vs. a computer assisted image analysis system. Appl Immunohistochem 3 (1995) 75-84
3. Bell D.S., Bamber J.C., and Eckersley R.J. Segmentation and analysis of colour Doppler images of tumour vasculature. Ultrasound Med Biol 21 (1995) 635-637
4. Bland J.M., and Altman D.G. Multiple significance tests: the Bonferroni method. BMJ 310 (1995) 170
5. Bohm-Velez M., and Mendelson E.B. Computed tomography, duplex Doppler ultrasound and magnetic resonance imaging in evaluating the breast. Semin Ultrasound CT MR 10 (1989) 171-176
6. Carmeliet P., and Jain R.K. Angiogenesis in cancer and other diseases. Nature 407 (2000) 249-257
7. Chaudhari M.H., Forsberg F., Voodarla A., Saikali F.N., Goonewardene S., Needleman L., Finkel G.C., and Goldberg B.B. Breast tumor vascularity identified by contrast enhanced ultrasound and pathology: Initial results. Ultrasonics 38 (2000) 105-109
8. de Jong J.S., van Diest P.J., and Baak J.P. Hot spot microvessel density and the mitotic activity index are strong additional prognostic indicators in invasive breast cancer. Histopathology 36 (2000) 306-312
9. Fleischer A.C. Sonographic depiction of tumor vascularity and flow from in vivo models to clinical applications. J Ultrasound Med 19 (2000) 55-61
10. Ferrara K.F., Merritt C.R.B., Burns P.N., Foster S., Mattrey R.F., and Wickline S.A. Evaluation of tumor angiogenesis with US: Imaging, Doppler and contrast agents. Acad Radiol 7 (2000) 824-839
11. Folkman J. What is the evidence that tumors are angiogenesis dependent?. J Natl Canc Inst 82 (1990) 4-6
12. Forsberg F., Dicker A.P., Thakur M.L., Rawool N.M., Liu J.B., Shi W.T., and Nazarian L.N. Comparing contrast enhanced ultrasound to immunohistochemical markers of angiogenesis in a human melanoma xenograft model: Preliminary results. Ultrasound Med Biol 28 (2002) 445-451
13. Forsberg F., Goldberg B.B., Merritt C.R.B., Parker L., Maitino A.J., Palazzo J.J., Merton D.A., Schultz S.M., and Needleman L. Diagnosing breast lesions with contrast-enhanced 3-dimensional power Doppler imaging. J Ultrasound Med 23 (2004) 173-182
14. Forsberg F., Liu J.B., Burns P.N., Merton D.A., and Goldberg B.B. Artifacts in ultrasonic contrast agent studies. J Ultrasound Med 13 (1994) 357-365
15. Forsberg F., Merton D.A., and Goldberg B.B. In vivo destruction of ultrasound contrast microbubbles is independent of the Mechanical Index. (letter). J Ultrasound Med 25 (2006) 143-144
16. Forsberg F., Merton D.A., Liu J.B., Needleman L., and Goldberg B.B. Clinical applications of ultrasound contrast agents. Ultrasonics 36 (1998) 695-701
17. Forsberg F., Shi W.T., Merritt C.R.B., Dai Q., Solcova M., and Goldberg B.B. On the usefulness of the mechanical index displayed on clinical ultrasound scanners for predicting contrast microbubble destruction. J Ultrasound Med 24 (2005) 443-450
18. Gasparini G., and Harris A.L. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 13 (1995) 765-782
19. Goldberg B.B., Raichlen J.S., and Forsberg F. Ultrasound Contrast Agents: Basic Principles and Clinical Applications. 2nd ed. (2001), Martin Dunitz Ltd, London, England
20. Hlatky L., Hahnfeldt P., and Folkman J. Clinical application of antiangiogenic therapy: Microvessel density, what it does and doesn't tell us. J Natl Canc Inst 94 (2002) 883-893
21. Hochmuth A., Boehm T., Bitzer C., Fleck M., Schneider A., and Kaiser W.A. Differentiation of breast masses using 3-D sonographic and echo-enhancer-based evaluation of the vascular pattern: Initial experiences. Ultrasound Med Biol 28 (2002) 845-851
22. Huber S., Vesely M., Zuna I., Delorme S., and Czembirek H. Fibroadenomas: Computer-assisted quantitative evaluation of contrast-enhanced power Doppler features and correlation with histopathology. Ultrasound Med Biol 27 (2001) 3-11
23. Kedar R.P., Cosgrove D., McCready V.R., Bamber J.C., and Carter E.R. Microbubbble contrast agent for color Doppler US: Effect on breast masses. Radiology 198 (1996) 679-686
24. Kettenbach J., Helbich T.H., Huber S., Zuna I., and Dock W. Computer-assisted quantitative assessment of power Doppler US: Effects of microbubble contrast agent in the differentiation of breast tumors. Eur J Radiol 53 (2005) 238-244
25. Kim S.W., Park S.S., Ahn S.J., Moon W.K., Im J.G., Yeo J.S., Chung J.K., and Noh D.Y. Identification of angiogenesis in primary breast carcinoma according to the image analysis. Breast Cancer Res Treat 74 (2002) 121-129
26. Kopans D.B. Breast Imaging. 2nd ed. (1998), Lippincott Williams & Wilkins, Philadelphia, PA
27. Li W.W. Tumor angiogenesis: Molecular pathology, therapeutic targeting, and imaging. Acad Radiol 7 (2000) 800-811
28. Madjar H., Prompeler H.J., Del Favero C., Hackeloer B.J., and Llull J.B. A new Doppler signal enhancing agent for flow assessment in breast lesions. Eur J Ultrasound 12 (2000) 123-130
29. Martinez A.M., Medina C.J., Bustos C., and Hernandez J.A. Assessment of breast lesions using Doppler with contrast agents. Eur J Gynaecol Oncol 24 (2003) 527-530
30. Newman P.J. The biology of PECAM-1. J Clin Invest 99 (1997) 3-8
31. Özdemir A., Kilic K., Özdemir H., Yucel C., Andac S., and Colak M. Contrast-enhanced power Doppler sonography in breast lesions: Effect on differential diagnosis after mammography and gray scale sonography. J Ultrasound Med 23 (2004) 183-195
32. Perneger T.V. What's wrong with Bonferroni adjustments?. Br Med J 316 (1998) 1236-1238
33. Rosner B. Fundamentals of Biostatistics. 3rd ed. (1990), PWS-Kent Publishing Co, Boston, MA
34. Stavros A.T., Thickman D., Rapp C.L., Dennis M.A., Parker S.H., and Sisney G.A. Solid breast nodules: Use of sonography to distinguish between benign and malignant lesions. Radiology 196 (1995) 123-134
35. Stuhrmann M., Aronius R., and Schietzel M. Tumor vascularity of breast lesions: Potentials and limits of contrast-enhanced Doppler sonography. Am J Roentgenol 175 (2000) 1585-1589
36. Tabár L., and Dean P.B. Mammography and breast cancer: The new era. Int J Gynaecol Obstet 82 (2003) 319-326
37. Taylor K.J., Merritt C., Piccoli C., Schmidt R., Rouse G., Fornage B., Rubin E., Georgian-Smith D., Winsberg F., Goldberg B., and Mendelson E. Ultrasound as a complement to mammography and breast examination to characterize breast masses. Ultrasound Med Biol 28 (2002) 19-26
38. Weidner N., Folkman J., Pozza F., Bevilacqua P., Allred E.N., Moore D.H., Meli S., and Gasparini G. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma. J Natl Cancer Inst 84 (1992) 1875-1887
39. Weidner N., Semple J.P., Welch W.R., and Folkman J. Tumor angiogenesis and metastasis-Ccorrelation in invasive breast carcinoma. N Engl J Med 324 (1991) 1-8
40. Yang W.T., Tse G.M.K., Lam P.K.W., Metreweli C., and Chang J. Correlation between color power Doppler sonographic measurement of tumor vasculature and immunohistochemical analysis of microvessel density for the quantitation of angiogenesis. J Ultrasound Med 21 (2002) 1227-1235
41. Zonderland H.M., Coerkamp E.G., Hermans J., van de Vijver M.J., and van Voorthuisen A.E. Diagnosis of breast cancer: Contribution of US as an adjunct to mammography. Radiology 213 (1999) 413-422